1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > The Global Blood Industry

The Global Blood Industry

  • March 2015
  • -
  • BCC Research
  • -
  • 270 pages

REPORT HIGHLIGHTS

Global sales of blood products grew to nearly $30.2 billion in 2014 from $28.7 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2014 to 2019, totaling nearly $38.3 billion in 2019.

This report provides:

An overview of the structure and current market size of the global blood industry, including coverage of such segments as blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products.
Analyses of global market trends, with data from 2011 to 2014, and projections of CAGRs through 2019.
Government and regulatory controls.
The impact of diseases on the blood industry.
Comprehensive company profiles of major players in the industry.

SCOPE AND FORMAT

This study encompasses the wide range of products and services that comprise the global blood industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

Table Of Contents

The Global Blood Industry

Chapter- 1: Introduction - Complimentary 4

STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 3

OVERVIEW
MAJOR FINDINGS

Chapter- 3: OVERVIEW 31

THE BLOOD INDUSTRY
BLOOD INDUSTRY TERMS AND ABBREVIATIONS[1]
HISTORY OF THE BLOOD INDUSTRY
BLOOD AND ITS COMPONENTS

Chapter- 4: THE BLOOD MANAGEMENT SYSTEM: BLOOD COLLECTION, PROCESSING AND USE 43

BLOOD COLLECTION
BLOOD MANAGEMENT ISSUES

Chapter- 5: REGULATION OF THE BLOOD BUSINESS 14

REGULATION OF THE U.S. BLOOD BUSINESS

Chapter- 6: THE GLOBAL BLOOD AND BLOOD PRODUCTS MARKET OVERVIEW 10

DRIVING FORCES OF THE INDUSTRY
MARKET SUMMARY

Chapter- 7: BLOOD INDUSTRY ANALYSIS 78

GLOBAL MARKETS FOR WHOLE BLOOD COLLECTIONS
GLOBAL MARKETS FOR SOURCE PLASMA COLLECTIONS
GLOBAL MARKETS FOR BLOOD THERAPEUTICS
GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS
SCREENING BLOOD
MARKET SIZE OF BLOOD TESTING PRODUCTS FOR DONOR SCREENING
BLOOD TYPING
GLOBAL MARKETS FOR BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS

Chapter- 8: BLOOD RESEARCH AND DEVELOPMENT 7

DEDICATED BLOOD RESEARCH FACILITIES
STEM CELL RESEARCH
BLOOD SUBSTITUTES
RECOMBINANT DEVELOPMENT ACTIVITIES
NEW DEVELOPMENTS IN IMMUNOGLOBULINS
CSL BEHRING'S COMMITMENT TO CLOTTING FACTOR DEVELOPMENT
FIBRIN SEALANT AND GLUE DEVELOPMENTS
ALBUMIN AND IVIG TREATMENT FOR ALZHEIMER'S DISEASE
INVESTIGATIONAL DEVICE TO HELP IMPROVE BLOOD SUPPLY SAFETY
THE VETERINARY BLOOD MARKET

Chapter- 9: TECHNOLOGY 16

CLASSICAL FRACTIONATION METHODS
ADVANCED FRACTIONATION METHODS
AMPLIFICATION METHODS
IMMUNOASSAY
PATENT ANALYSIS
PATENT EXAMPLES

Chapter- 10: FDA LICENSED BLOOD ESTABLISHMENTS 24

GUIDANCE FOR INDUSTRY RECOGNITION AND USE OF A STANDARD FOR THE UNIFORM LABELING OF BLOOD AND BLOOD COMPONENTS

Chapter- 11: COMPANY PROFILES 23

ABBOTT LABORATORIES
ASTRAZENECA PLC
BAXTER INTERNATIONAL INC.
BAYER AG
BIO-RAD LABORATORIES INC.
CSL BEHRING
ENTEGRION INC.
GRIFOLS INTERNATIONAL, S.A./TALECRIS
HAEMONETICS CORP.
HOLOGIC INC.
LFB GROUP
NOVO NORDISK A/S
OCTAPHARMA AG
PFIZER INC.
ROCHE HOLDING LTD.
SANOFI S/A

Chapter- 12: APPENDIX: MAJOR SOURCES OF INFORMATION 17

COMPANIES
GLOBAL BLOOD DONATION SOURCES

List of Tables

Summary Table : GLOBAL SALES OF BLOOD PRODUCTS, THROUGH 2019
Table 1 : TIMELINE OF THE BLOOD INDUSTRY
Table 2 : COMPOSITION OF BLOOD
Table 3 : MAJOR DISEASES CONTRACTED FROM BLOOD TRANSFUSIONS, U.S. ANALYSIS
Table 4 : CBER LICENSED HIV DONOR SCREENING TESTS
Table 5 : CBER-LICENSED SCREENING TESTS FOR HEPATITIS B
Table 6 : CBER-LICENSED SCREENING TESTS FOR HEPATITIS C
Table 7 : CBER-LICENSED SCREENING TESTS FOR HTLV-I AND HTLV-II
Table 8 : CBER-LICENSED SCREENING TESTS FOR CMV
Table 9 : CBER LICENSED SCREENING TESTS FOR WEST NILE
Table 10 : CBER-APPROVED MANUFACTURERS FOR SYPHILIS TESTS
Table 11 : CBER-LICENSED SCREENING TESTS FOR T. CRUZI
Table 12 : CBER-APPROVED MANUFACTURERS FOR CHLAMYDIA SCREENING TESTS
Table 13 : CBER-LICENSED SCREENING TESTS FOR GONORRHEA
Table 14 : FDA-REGISTERED BLOOD ESTABLISHMENTS BY STATE¹ AND POSSESSION
Table 15 : ESTIMATED WORLD POPULATION ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030
Table 16 : GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
Table 17 : U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Table 18 : ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020
Table 19 : EUROPE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Table 20 : ASIA-PACIFIC POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Table 21 : GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013
Table 22 : TESTS ROUTINELY PERFORMED ON BLOOD DONATIONS
Table 23 : BLOOD TYPE ANTIGEN/ANTIBODY REACTIONS
Table 24 : SELECTED USES OF FFP
Table 25 : LISTING OF BLOOD PRODUCTS FOR THERAPEUTIC USE
Table 26 : FACTORS TO REDUCE RISKS OF TRANSFUSION-ASSOCIATED DISEASES
Table 27 : TRANSFUSION-RELATED FATALITIES BY COMPLICATION, FY2008 -FY2012
Table 28 : FATALITIES NOT RELATED TO TRANSFUSION OR TRANSFUSION NOT RULED OUT, FY2008-FY2012
Table 29 : POST-DONATION "NOT RULED OUT” FATALITY REPORTS BY DONATED PRODUCT, FY2008-FY2012
Table 30 : FEDERAL ORGANIZATIONS RESPONSIBLE FOR U.S. BLOOD SAFETY
Table 31 : FDA AUTHORITY IN REGULATING BLOOD BANKING AND BLOOD PRODUCTS
Table 32 : MAJOR AREAS OF CONCERN FOR INSPECTING BLOOD FACILITIES
Table 33 : U.S. COST OF BLOOD COMPONENTS, ESTIMATED, THROUGH 2014
Table 34 : U.S. BLOOD TRANSFUSION AND RELATED SERVICES CODES
Table 35 : U.S. BLOOD COLLECTION AND TRANSFUSION DATA, THROUGH 2019*
Table 36 : ESTIMATED AND PROJECTED GLOBAL PLASMA COLLECTIONS AND VALUES, THROUGH 2019
Table 37 : GLOBAL SALES OF PLASMA THERAPEUTICS*, THROUGH 2019
Table 38 : GLOBAL MARKET SIZE PLASMA THERAPEUTIC DERIVATIVES BY TYPE, THROUGH 2019
Table 39 : ALBUMIN AND PLASMA PROTEIN FRACTION (PPF) PRODUCTS
Table 40 : GLOBAL MARKET FOR ALBUMIN AND PPF, THROUGH 2019
Table 41 : GLOBAL MARKET FOR ALBUMIN AND PPF BY REGION, THROUGH 2019
Table 42 : EXAMPLES OF COMMON BLOOD CLOTTING FACTORS
Table 43 : GLOBAL AND U.S. HEMOPHILIA STATISTICS
Table 44 : GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS, THROUGH 2019
Table 45 : GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS BY REGION, THROUGH 2019
Table 46 : APPROVED FACTOR VIII PRODUCTS
Table 47 : GLOBAL MARKET SHARE FACTOR VIII COMPANIES, 2014
Table 48 : APPROVED FACTOR IX PRODUCTS
Table 49 : GLOBAL MARKET SHARE FACTOR IX COMPANIES, 2014
Table 50 : APPROVED FACTOR VII PRODUCTS
Table 51 : GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014
Table 52 : APPROVED FACTOR XIII PRODUCTS
Table 53 : APPROVED PROTHROMBIN COMPLEX CONCENTRATE PRODUCTS
Table 54 : SELECTED CONDITIONS TREATED BY IVIG
Table 55 : APPROVED IMMUNOGLOBULINS
Table 56 : APPROVED HYPERIMMUNE IMMUNOGLOBULINS
Table 57 : GLOBAL MARKET FOR IMMUNOGLOBULINS, THROUGH 2019
Table 58 : GLOBAL MARKET FOR IMMUNOGLOBULINS BY REGION, THROUGH 2019
Table 59 : GLOBAL MARKET SHARE OF IMMUNOGLOBULIN COMPANIES, 2014
Table 60 : APPROVED FIBRIN SEALANTS AND FIBRIN PRODUCTS
Table 61 : GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN, THROUGH 2019
Table 62 : GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN BY REGION, THROUGH 2019
Table 63 : GLOBAL MARKET SHARE OF FIBRIN SEALANTS AND THROMBIN PRODUCT COMPANIES, 2014
Table 64 : APPROVED ANTITHROMBIN PRODUCTS
Table 65 : GLOBAL MARKET FOR ANTITHROMBIN, THROUGH 2019
Table 66 : GLOBAL MARKET FOR ANTITHROMBIN BY REGION, THROUGH 2019
Table 67 : GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS BY REGION, THROUGH 2019
Table 68 : GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS, THROUGH 2019
Table 69 : SELECTED PCR DONOR SCREENING TESTS
Table 70 : SELECTED NAT DONOR SCREENING TESTS
Table 71 : SELECTED IMMUNOASSAY DONOR SCREENING TESTS
Table 72 : GLOBAL BLOOD DONOR SCREENING TESTING MARKET BY TYPE OF TESTS, THROUGH 2019
Table 73 : BLOOD GROUP AND RH TYPE AND COMPATIBLE BLOOD FOR TRANSFUSION
Table 74 : GLOBAL BLOOD TYPING MARKET: INSTRUMENTS AND SUPPLIES BY TYPE, THROUGH 2019
Table 75 : GLOBAL SALES OF BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLES, THROUGH 2019
Table 76 : GLOBAL MARKET FOR BLOOD AND PLASMA COLLECTION/ TRANSFUSION PRODUCTS, THROUGH 2019
Table 77 : GLOBAL MARKET FOR BLOOD COLLECTION PRODUCTS BY TYPE, THROUGH 2019
Table 78 : GLOBAL MARKET FOR TRANSFUSION PRODUCTS BY TYPE, THROUGH 2019
Table 79 : CLINICAL TRIAL: ALBUMIN IN ALZHEIMER'S TREATMENT
Table 80 : DOG AND CAT BLOOD TYPES AND DESCRIPTIONS
Table 81 : REGIONAL VETERINARY BLOOD BANKS
Table 82 : RECENTLY ISSUED PATENTS
Table 83 : PATENTS BY COUNTRY OF ORIGIN
Table 84 : RECENT PATENTS BY ASSIGNEE
Table 85 : ABBOTT'S SALES HISTORY, 2012-2014*
Table 86 : ASTRAZENECA'S SALES HISTORY, 2012-2014*
Table 87 : BAXTER'S SALES HISTORY, 2012-2014*
Table 88 : BAYER'S SALES HISTORY, 2012-2014*
Table 89 : BIO-RAD'S SALES HISTORY, 2012-2014*
Table 90 : CSL LIMITED'S SALES HISTORY, 2012-2014*
Table 91 : GRIFOLS' SALES HISTORY, 2012-2014*
Table 92 : HAEMONETICS' SALES HISTORY, 2012-2014*
Table 93 : HOLOGIC'S SALES HISTORY, 2012-2014
Table 94 : LFB GROUP'S SALES HISTORY, 2012-2013
Table 95 : NOVO NORDISK'S SALES HISTORY, 2012-2014*
Table 96 : OCTAPHARMA'S SALES HISTORY, 2012-2014*
Table 97 : PFIZER'S SALES HISTORY, 2012-2014*
Table 98 : ROCHE'S SALES HISTORY, 2012-2014*
Table 99 : SANOFI'S SALES HISTORY, 2012-2014*

List of Figures

Summary Figure : GLOBAL SALES OF BLOOD PRODUCTS, 2011-2019
Figure 1 : ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030
Figure 2 : GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND 2015
Figure 3 : U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Figure 4 : ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000-2020
Figure 5 : EUROPE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Figure 6 : ASIA-PACIFIC POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2050
Figure 7 : GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013
Figure 8 : VARIABLES INFLUENCING THE DYNAMICS OF DEMAND FOR BLOOD FOR TRANSFUSION
Figure 9 : BLOOD MARKET COST AND PRICING ANALYSIS
Figure 10 : U.S. BLOOD COLLECTION AND TRANSFUSION DATA, 2007-2019
Figure 11 : ESTIMATED AND PROJECTED GLOBAL PLASMA COLLECTIONS MARKET VALUE, 2013-2019
Figure 12 : GLOBAL SALES OF PLASMA THERAPEUTICS*, 2011-2019
Figure 13 : MARKET SHARE FOR PLASMA THERAPEUTIC SALES BY REGION, 2014
Figure 14 : GLOBAL MARKET SIZE PLASMA THERAPEUTIC DERIVATIVES BY TYPE, 2011-2019
Figure 15 : GLOBAL MARKET FOR ALBUMIN AND PPF, 2011-2019
Figure 16 : GLOBAL MARKET FOR ALBUMIN AND PPF BY REGION, 2011-2019
Figure 17 : GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS, 2011-2019
Figure 18 : GLOBAL MARKET SHARE OF CLOTTING FACTOR SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014
Figure 19 : GLOBAL MARKET FOR PLASMA-DERIVED AND RECOMBINANT CLOTTING FACTORS BY REGION, 2011-2019
Figure 20 : GLOBAL MARKET SHARE OF FACTOR VIII COMPANIES, 2014
Figure 21 : GLOBAL MARKET SHARE OF FACTOR VIII SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014
Figure 22 : GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014
Figure 23 : GLOBAL MARKET SHARE OF FACTOR IX SALES BY HUMAN AND RECOMBINANT PRODUCTS, 2014
Figure 24 : GLOBAL MARKET SHARE OF FACTOR IX COMPANIES, 2014
Figure 25 : GLOBAL MARKET FOR IMMUNOGLOBULINS, 2011-2019
Figure 26 : GLOBAL MARKET FOR IMMUNOGLOBULINS BY REGION, 2011-2019
Figure 27 : GLOBAL MARKET SHARE OF IMMUNOGLOBULIN COMPANIES, 2014
Figure 28 : GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN, 2011- 2019
Figure 29 : GLOBAL MARKET FOR FIBRIN SEALANTS AND THROMBIN BY REGION, 2011-2019
Figure 30 : GLOBAL MARKET SHARE OF FIBRIN SEALANTS AND THROMBIN PRODUCT COMPANIES, 2014
Figure 31 : GLOBAL MARKET FOR ANTITHROMBIN, 2011-2019
Figure 32 : GLOBAL MARKET FOR ANTITHROMBIN BY REGION, 2011-2019
Figure 33 : GLOBAL MARKETS FOR BLOOD TYPING AND SCREENING PRODUCTS BY REGION, 2011-2019
Figure 34 : MARKET SHARE FOR BLOOD TYPING AND SCREENING PRODUCT SALES BY REGION, 2014
Figure 35 : GLOBAL MARKET FOR BLOOD TYPING AND SCREENING PRODUCTS, 2011-2019
Figure 36 : GLOBAL BLOOD DONOR SCREENING TESTING MARKET BY TYPE OF TEST, 2011- 2019
Figure 37 : GLOBAL BLOOD TYPING MARKET: INSTRUMENTS AND SUPPLIES BY TYPE, 2011-2019
Figure 38 : GLOBAL SALES OF BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLES, 2011-2019
Figure 39 : MARKET SHARE FOR BLOOD COLLECTION AND PROCESSING EQUIPMENT AND DISPOSABLE SALES BY REGION, 2014
Figure 40 : GLOBAL MARKET FOR BLOOD AND PLASMA COLLECTION/ TRANSFUSION PRODUCTS, 2011-2019
Figure 41 : GLOBAL MARKET FOR COLLECTION PRODUCTS BY TYPE, 2011-2019
Figure 42 : GLOBAL MARKET FOR TRANSFUSION PRODUCTS BY TYPE, 2011-2019
Figure 43 : THE BASIC ENZYME IMMUNOASSAY (EIA) PROCESS
Figure 44 : ABBOTT'S SALES HISTORY, 2012-2014*
Figure 45 : ASTRAZENECA'S SALES HISTORY, 2012-2014*
Figure 46 : BAXTER'S SALES HISTORY, 2012-2014*
Figure 47 : BAYER'S SALES HISTORY, 2012-2014*
Figure 48 : BIO-RAD'S SALES HISTORY, 2012-2014*
Figure 49 : CSL LIMITED'S SALES HISTORY, 2012-2014*
Figure 50 : GRIFOLS' SALES HISTORY, 2012-2014*
Figure 51 : HAEMONETICS' SALES HISTORY, 2012-2014*
Figure 52 : HOLOGIC'S SALES HISTORY, 2012-2014
Figure 53 : LFB GROUP'S SALES HISTORY, 2012-2013
Figure 54 : NOVO NORDISK'S SALES HISTORY, 2012-2014*
Figure 55 : OCTAPHARMA'S SALES HISTORY 2012-2014*
Figure 56 : PFIZER'S SALES HISTORY, 2012-2014*
Figure 57 : ROCHE'S SALES HISTORY, 2012-2014*
Figure 58 : SANOFI'S SALES HISTORY, 2012-2014*

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Blood Banking Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Blood Banking Market 2015: Supplier Shares and Country Forecasts

  • $ 19 500
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $35,500.  DataPack (test volumes, sales forecasts, supplier shares) $19,500. “Future Horizons and Growth Strategies in the Global Blood Banking Market 2015” is a new seven-country strategic ...

Blood Testing: Technology and Global Markets

Blood Testing: Technology and Global Markets

  • $ 6 650
  • Industry report
  • March 2015
  • by BCC Research

REPORT HIGHLIGHTS The blood testing market totaled $49.5 billion in 2013 and reached to nearly $50 billion in 2014 This market is expected to grow $56.6 billion in 2019, with a compound annual growth ...

Blood Screening Market by Technology, Product & End User - Forecasts to 2019

Blood Screening Market by Technology, Product & End User - Forecasts to 2019

  • $ 4 650
  • Industry report
  • May 2015
  • by MarketsandMarkets

The blood screening market size is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, at a CAGR of 10.4%. This market is categorized on the basis of products and services, technologies, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.